StockWatch
·
Pharmaceuticals
Promoter Reclassification25 Jul 2026, 12:30 pm

Hester Biosciences: NSE/BSE Grant NOC for Promoter Reclassification

AI Summary

Hester Biosciences Ltd announced that both the National Stock Exchange (NSE) and BSE Limited have issued their No-Objection Certificates (NOCs) for the re-classification application filed on May 19, 2026. The company received approval letters dated July 24, 2026, from NSE and BSE, granting their no-objection for re-classifying Mr. Ravin Gandhi and Ms. Bela Gandhi from the Promoter Group to the Public category, in accordance with Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has been requested to ensure compliance with subsequent disclosures related to this reclassification.

Key Highlights

  • NSE and BSE have issued NOCs for promoter re-classification.
  • Ravin Gandhi and Bela Gandhi to be re-classified from Promoter to Public.
  • Re-classification is in accordance with SEBI LODR Regulations, 2015.
  • Company to ensure compliance with further disclosure requirements.